Companies: 10,795·Total market cap: $144.5T
BioSyent Inc.

BioSyent Inc.

BIOYFOTCHealthcare● Active
$9.97
+$0.16(+1.63%)
Market Cap$114040030
P/E Ratio
52W High$12
52W Low$7.63

BioSyent Inc.(BIOYF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BIOYF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$43.02M$35.03M$31.59M$27.93M$28.62M
Cost of Revenue$10.93M$7.17M$5.99M$5.07M$5.98M
Gross Profit$32.08M$27.86M$25.60M$22.86M$22.64M
Gross Margin %(computed)74.59%79.52%81.03%81.85%79.10%
Operating Expenses
R&D Expenses$0.34M$0.17M$0.08M$0.22M$0.28M
G&A Expenses$0.00M$10.79M$18.01M$8.86M$4.58M
Total Operating Expenses$20.78M$19.10M$18.13M$15.95M$14.39M
Operating Income$11.30M$8.75M$7.47M$6.98M$8.18M
Operating Margin %(computed)26.28%24.99%23.65%25.00%28.59%
Interest Income$0.81M$1.09M$1.13M$0.53M$0.14M
Interest Expense$0.05M$0.06M$0.07M$0.08M$0.09M
Income Before Tax$12.02M$9.78M$8.53M$7.43M$8.38M
Income Tax Expense$3.02M$2.51M$2.07M$1.97M$2.10M
Net Income$9.00M$7.27M$6.46M$5.46M$6.28M
Net Margin %(computed)20.93%20.75%20.45%19.55%21.95%
Per Share & EBITDA
EPS (Basic)$0.80$0.64$0.53$0.44$0.50
Wtd Avg Shares11.26M11.37M12.17M12.30M12.69M
EBITDA$12.16M$10.43M$7.76M$7.43M$8.64M
EBITDA Margin %(computed)28.26%29.78%24.58%26.62%30.19%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · M

深入了解BioSyent Inc.

关于BioSyent Inc.(BIOYF)损益表

BioSyent Inc.(BIOYF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BIOYF实现营收$0.04B,毛利润$0.03B(毛利率74.59%),净利润$0.01B(净利率20.93%)。

常见问题

BIOYF · 4 问

BioSyent Inc.(BIOYF)2025财年营收为$0.04B,同比up22.8%。

BIOYF revenueBIOYF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09